combines SNY’s influenza recombinant protein-based trivalent vaccine, Flublok with NVXC19. SNY markets Fluzone High-Dose and Flublok flu vaccines. Novavax recently signed a multi-billion dollar ...
Hosted on MSN2mon
Sanofi’s combo vaccines gain FDA fast track designationSanofi has announced that its two combination vaccine candidates, designed to prevent both influenza and Covid-19 infections in people aged 50 years and above, have received fast track designation ...
Fluzone quadrivalent vaccine, which is designed to protect against four different flu viruses; two influenza A viruses and two influenza B viruses. It is approved for anyone ages 6 months and older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback